Two Hands Corporation Announces Focused Listing in The US on The OTC & Voluntary Delisting from The Canadian Securities Exchange

Executive Summary

• Two Hands Corporation has received approval from the Canadian Securities Exchange (CSE) to voluntarily delist its common shares from the CSE.
• The company will continue to trade on the OTC Markets under the symbol "TWOH," with general trading remaining unaffected.
• The decision aims to reduce administrative burdens, eliminate duplicative exchange fees, and optimize financing initiatives as the company transitions focus toward the quantum computing and artificial intelligence industries.

Key Details

• Action Taken: Voluntary delisting from the Canadian Securities Exchange (CSE).
• Approval Status: Approved by the CSE and the Company's Board of Directors on June 29, 2026.
• Trading Status: Common shares will continue to trade on the OTC under the symbol "TWOH."
• Final Trading Day: The close of business on July 7, 2026, is expected to be the final trading day on the CSE.
• Rationale: The move is intended to provide greater market agility, reduce legal and accounting expenses, minimize regulatory complexity, and allow management to focus on opportunity capture in the quantum computing and AI sectors.
• Regulatory Status: The Company will remain a reporting issuer in certain jurisdictions in Canada and the United States and will remain subject to continuous disclosure requirements in both countries.
• Shareholder Action: No action is required by shareholders; those with account-specific questions are advised to contact their brokers.

Notable Quotes

• "The decision to focus on US markets and voluntarily delist from the Canadian exchange was taken following a comprehensive evaluation of Two Hands's regulatory framework which includes costs, administrative requirements and transaction opportunities. It was eventually determined the Company would have potentially greater market agility and transaction velocity without having to maintain a dual listing on the CSE and the OTC."